Areas of Activity

Contact us

25 November 2021

Research Suggests COVID-19 Affects Erectile Function

Researchers in Urology find that men infected with COVID-19 would be more likely to experience ED.


"One of the repercussions of COVID-19 is its impact on men's sexual health.  COVID-19 infection is expected to be associated with an increased likelihood of erectile dysfunction (ED).  Considering the high transmissibility of COVID-19, ED could be a concerning consequence for a large segment of the population" https://www.ncbi.nim.nih.gov/pmc/articles/PMC8450276/.

Coincidentally, DirexGroup introduces MoreNova (Renova's follow-up) to the Australian market.
Patented Large Area Shockwaves Technology (LAST) provides delivery of low intensity shockwaves - covering whole regions - for ED treatment as well as Wound Healing (Diabetic Foot Ulcers - DFU).  Arm mounted applicators free Operator to engage in other tasks during six painless sessions for ED, or about twelve sessions for DFU, treatment of seated patients.

Recent and encouraging results, for treatment of Stress Urinary Incontinence (SUI) as well as Female Sexual Improvement (FSI), were presented at medical conferences.
Sites interested in pilot studies are encouraged to contact This email address is being protected from spambots. You need JavaScript enabled to view it..

About DirexGroup:
For over 35 years, DirexGroup has been promoting companies contributing to global Health and Wellness by introducing shockwaves and other devices with emphasis on simplicity, comfort and convenience. Contact This email address is being protected from spambots. You need JavaScript enabled to view it.

About Hikkonu:
Hikkonu, promoted by DirexGroup, is focused on developing innovative and shockwaves-based devices for treating shallow and deep organs.
Hikkonu seeks investigators, distributors and partners.

Contact Us

© 2017 DirexGroup. All Rights Reserved.